Last reviewed · How we verify
Amphion® Mouthwash — Competitive Intelligence Brief
marketed
Oral Health / Dentistry
Small molecule
Live · refreshed every 30 min
Target snapshot
Amphion® Mouthwash (Amphion® Mouthwash) — Second Affiliated Hospital, School of Medicine, Zhejiang University. Amphion® Mouthwash is an oral rinse formulation designed to promote oral health and manage oral conditions through antimicrobial and/or anti-inflammatory action.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Amphion® Mouthwash TARGET | Amphion® Mouthwash | Second Affiliated Hospital, School of Medicine, Zhejiang University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Amphion® Mouthwash CI watch — RSS
- Amphion® Mouthwash CI watch — Atom
- Amphion® Mouthwash CI watch — JSON
- Amphion® Mouthwash alone — RSS
Cite this brief
Drug Landscape (2026). Amphion® Mouthwash — Competitive Intelligence Brief. https://druglandscape.com/ci/amphion-mouthwash. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab